Novartis Acquires Global Rights to Sironax Brain-Delivery Platform for $125 Million
The Swiss pharmaceutical group has exercised its option to acquire Sironax’s technology for transporting large therapeutic molecules across the blood-brain barrier. Novartis has exercised its exclusive option to acquire full global rights to Sironax’s…